Insulin causes weight gain through several overlapping mechanisms: it signals your body to store fat, prevents stored fat from being broken down, tells your kidneys to hold onto more sodium and water, and stops calories from being lost in urine. For people starting insulin therapy for diabetes, the average weight gain is about 1.8 kg (4 pounds) in the first year, though roughly one in four people gain 5 kg (11 pounds) or more.
Understanding exactly how insulin shifts your body toward weight gain can help make sense of what’s happening, whether you’re taking insulin as medication or simply curious about how the hormone works.
Insulin Pushes Your Body Into Storage Mode
Insulin is fundamentally a storage hormone. When it rises after a meal, it flips a metabolic switch that tells your cells to take in glucose and use it to build fat. In fat cells specifically, insulin drives a process where glucose provides the raw materials for assembling triglycerides (the molecules your body uses to store fat). Glucose supplies the carbon backbone, the energy needed to run the assembly line, and a key molecule called glycerol 3-phosphate that acts as the scaffold for new fat molecules.
At the same time, insulin suppresses fat burning. It deactivates an enzyme inside fat cells that acts as the rate-limiting step for breaking down stored triglycerides into free fatty acids your body could use for fuel. When insulin is high, this enzyme stays switched off, and fat stays locked in storage. So insulin doesn’t just build new fat. It also prevents the breakdown of fat you already have. The combination is what makes chronically elevated insulin levels so effective at increasing body fat over time.
How Insulin Causes Water Retention
Not all insulin-related weight gain is fat. Insulin has a direct effect on the kidneys, causing them to retain more sodium. It activates multiple sodium-reabsorbing channels and pumps along the kidney’s filtration system, which pulls water back into the body along with the sodium. This antinatriuretic effect (meaning it opposes sodium excretion) can add several pounds of water weight relatively quickly after starting insulin therapy. It’s one reason the scale can jump in the first few weeks before any meaningful fat accumulation has occurred.
The Calorie Leak That Insulin Plugs
Before someone with diabetes starts insulin treatment, their blood sugar often runs high enough that glucose spills into the urine. This is essentially a calorie leak: your body is excreting energy instead of using or storing it. People sometimes unconsciously eat more to compensate for those lost calories without realizing it.
Once insulin therapy brings blood sugar under control, that leak stops. The glucose that was being flushed away now stays in the body, gets taken up by cells, and either fuels activity or gets stored. If eating habits don’t change to account for this shift, the extra retained calories translate directly into weight gain. This is one of the less obvious but more significant contributors, especially in the early months of treatment.
Defensive Eating Adds Extra Calories
Insulin therapy, particularly intensive regimens, carries a risk of blood sugar dropping too low. Hypoglycemia feels awful: shaky, sweaty, confused, sometimes frightening. People learn quickly to treat these episodes by eating fast-acting carbohydrates, and many start eating preemptively to avoid lows altogether. This pattern, sometimes called “defensive eating,” adds calories that wouldn’t otherwise be consumed.
The fear of hypoglycemia can be powerful enough to reshape someone’s entire relationship with food. Snacking before bed, eating extra before exercise, or keeping blood sugar slightly higher than necessary “just in case” all contribute to a caloric surplus that accumulates over weeks and months.
Insulin Also Builds Muscle
Insulin isn’t purely a fat-storage signal. It also promotes muscle protein synthesis by increasing blood flow to skeletal muscle. Insulin triggers the release of nitric oxide in blood vessel walls, which opens up capillaries and increases the volume of muscle tissue exposed to nutrients and amino acids. This enhanced delivery stimulates the molecular machinery that assembles new muscle protein. In practical terms, some of the weight gained on insulin therapy is lean tissue, not just fat, particularly in people who were previously losing muscle mass due to poorly controlled diabetes.
The Hyperinsulinemia Cycle
For people with type 2 diabetes or insulin resistance, the picture gets more complicated. Their bodies already produce large amounts of insulin to overcome cells that respond poorly to the hormone. This chronic hyperinsulinemia, high insulin circulating around the clock, independently drives fat storage. Research using genetic models has demonstrated that pathological hyperinsulinemia drives diet-induced obesity on its own, separate from diet composition or calorie intake. Reducing chronically elevated insulin levels in these models reprogrammed fat tissue to burn more energy, shrank fat cells back to normal size, and reduced liver fat accumulation.
When someone with existing hyperinsulinemia then adds exogenous insulin on top, the storage signals intensify. Visceral fat (the deep abdominal fat associated with metabolic disease) is particularly responsive to insulin, creating a feedback loop: more insulin promotes more visceral fat, which worsens insulin resistance, which requires more insulin.
How Much Weight Gain to Expect
A large study of over 2,100 people with type 2 diabetes starting insulin found an average gain of 1.78 kg (about 4 pounds) in the first year. But averages can be misleading. About 24% of participants gained 5 kg (11 pounds) or more in that same timeframe.
The data is more striking for intensive insulin regimens. In the landmark Diabetes Control and Complications Trial (DCCT), which followed people with type 1 diabetes for an average of 6.5 years, those on intensive insulin therapy gained 5.1 kg (about 11 pounds) in just the first year, compared to 2.4 kg (about 5 pounds) in the conventional treatment group. By the end of the trial, 33% of the intensive group met the criteria for obesity, compared to 19% in the conventional group. For every level of weight gain measured, the increase in BMI was roughly double in the intensive group.
Strategies That Reduce Insulin-Related Weight Gain
Combining insulin with newer medication classes can offset some of the weight effect. When people take both a GLP-1 receptor agonist (a class of drugs that reduces appetite and slows digestion) and an SGLT2 inhibitor (which causes excess glucose to be excreted in urine, essentially restoring the “calorie leak”), the average weight loss is about 3.5 kg, with nearly 40% of patients losing 5% or more of their body weight. These combinations also tend to reduce the insulin dose needed.
Beyond medication adjustments, the most practical lever is recognizing where the extra calories come from. Accounting for the calories no longer lost in urine, minimizing defensive snacking by fine-tuning insulin doses to reduce hypoglycemia, and focusing on foods that require less insulin coverage all help limit the surplus. Strength training can also shift the balance toward muscle gain rather than fat storage, taking advantage of insulin’s anabolic effects on skeletal muscle.